Ngoc Nguyen Hoang

State Capital Investment Corp. (Investment Management) (SCIC-IM) is the investment management division of State Capital Investment Corp., a wholly-owned special economic organization of the Vietnamese Government which was founded in 2005 to invest in Vietnam's state-owned enterprises and to make strategic investments in key industries. Headquartered in Hanoi, SCIC-IM’s primary objectives are to facilitate state-owned enterprise reforms and improve the efficiency of the State's capital utilization. They are mandated to represent State capital interest in various types of businesses and to invest in key sectors with an aim to enhance the economic role of the State subject to market rules.

State Capital Investment Corp. (SCIC) is a wholly-owned special economic organization of the Vietnamese Government which was established in 2005 by the Prime Minister of Vietnam to manage and invest state capital in Vietnam's state-owned enterprises and undertake strategic investments in key industries. Located in Hanoi and Ho Chi Minh City, SCIC's primary objectives are to facilitate state-owned enterprise reforms and improve the efficiency of the State's capital utilization. SCIC is mandated to represent State capital interest in various types of businesses and to invest in key sectors with an aim to enhance the dominant economic role of the State subject to market rules. SCIC aims to concentrate investment in key and strategic branches and domains which are a driving force in boosting economic development, paying attention to investment in fruitful and highly profitable branches and domains and reducing investment in branches and domains which the State does not need to control as well as branches and domains which are capable of attracting resources from other economic sectors. SCIC manages a portfolio of SOEs in a range of sectors including financial service, energy, industry, telecommunications, transportation, consumer products, health care, and information technology.

UPSA Belgium SA wholesales pharmaceutical products. The private company is based in Etterbeek, Belgium. The CEOs are Isabelle van Rycke, Jun Kuroda. The Belgian company was founded in 2019.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.